Qing Luo

792 total citations
21 papers, 495 citations indexed

About

Qing Luo is a scholar working on Molecular Biology, Cancer Research and Human-Computer Interaction. According to data from OpenAlex, Qing Luo has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Human-Computer Interaction. Recurrent topics in Qing Luo's work include Chromatin Remodeling and Cancer (3 papers), Hand Gesture Recognition Systems (3 papers) and Cancer Mechanisms and Therapy (2 papers). Qing Luo is often cited by papers focused on Chromatin Remodeling and Cancer (3 papers), Hand Gesture Recognition Systems (3 papers) and Cancer Mechanisms and Therapy (2 papers). Qing Luo collaborates with scholars based in China, United States and Australia. Qing Luo's co-authors include Guanbin Song, Jinghui Sun, Lingling Liu, Ze‐Guang Han, Yi Shi, Na Wang, Linan Zhao, Lan Wang, Xueying Shang and Xianbin Su and has published in prestigious journals such as Hepatology, Oncogene and Cancer Letters.

In The Last Decade

Qing Luo

21 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Luo China 11 246 133 94 51 49 21 495
Yifeng Zhang China 15 194 0.8× 141 1.1× 90 1.0× 94 1.8× 44 0.9× 34 637
Miaomiao Zhang China 14 237 1.0× 89 0.7× 201 2.1× 31 0.6× 25 0.5× 29 551
Ning He China 12 277 1.1× 62 0.5× 85 0.9× 71 1.4× 104 2.1× 56 625
Lei Yan China 10 248 1.0× 106 0.8× 75 0.8× 19 0.4× 48 1.0× 40 569
Lipei Liu China 16 358 1.5× 162 1.2× 77 0.8× 28 0.5× 28 0.6× 48 876
Menglin Zhu China 13 282 1.1× 84 0.6× 80 0.9× 29 0.6× 13 0.3× 29 613
Yali Cao China 14 330 1.3× 269 2.0× 140 1.5× 27 0.5× 29 0.6× 38 617
Luting Zhou China 14 304 1.2× 152 1.1× 72 0.8× 20 0.4× 26 0.5× 49 589

Countries citing papers authored by Qing Luo

Since Specialization
Citations

This map shows the geographic impact of Qing Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Luo more than expected).

Fields of papers citing papers by Qing Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Luo. The network helps show where Qing Luo may publish in the future.

Co-authorship network of co-authors of Qing Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Luo. A scholar is included among the top collaborators of Qing Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Luo. Qing Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Zhiyi, Qinghe Hu, Qing Luo, et al.. (2024). NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression. Oncogene. 43(44). 3255–3267. 3 indexed citations
3.
Cui, Xiaofang, Xueying Shang, Zhanyun Tang, et al.. (2023). Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression. Cancer Letters. 575. 216404–216404. 10 indexed citations
4.
Risal, Sanjiv, Qing Luo, Romina Fornes, et al.. (2023). Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome. Cell Reports Medicine. 4(5). 101035–101035. 27 indexed citations
5.
Wang, Lan, Qing Luo, Xianbin Su, et al.. (2022). Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer. Cancer Letters. 546. 215869–215869. 10 indexed citations
6.
Luo, Qing, Xiaomeng Chen, Alanson P. Sample, et al.. (2022). Automatic calibration of magnetic tracking. 391–404. 5 indexed citations
7.
Shang, Xueying, Yi Shi, Dandan He, et al.. (2021). ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis. Cell Death and Disease. 12(11). 990–990. 21 indexed citations
8.
Chen, Dongyao, et al.. (2021). MagX. 269–282. 24 indexed citations
9.
Zhao, Gang, et al.. (2021). An Adaptive Offset-Tracking Method Based on Deformation Gradients and Image Noises for Mining Deformation Monitoring. Remote Sensing. 13(15). 2958–2958. 11 indexed citations
10.
Su, Xianbin, Qi Long, Juanjie Bo, et al.. (2020). Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma. The Prostate. 80(6). 508–517. 14 indexed citations
11.
Shi, Yi, Luming Meng, Xianbin Su, et al.. (2020). A novel neoantigen discovery approach based on chromatin high order conformation. BMC Medical Genomics. 13(S6). 62–62. 3 indexed citations
12.
Luo, Qing, Xueying Shang, Jiaoxiang Wu, et al.. (2019). Arid1a regulates insulin sensitivity and lipid metabolism. EBioMedicine. 42. 481–493. 41 indexed citations
13.
Luo, Qing, Linan Zhao, Yi Shi, et al.. (2019). The Mutational Features of Aristolochic Acid–Induced Mouse and Human Liver Cancers. Hepatology. 71(3). 929–942. 71 indexed citations
14.
15.
Yuan, Yuchen, Yi Shi, Xianbin Su, et al.. (2018). Cancer type prediction based on copy number aberration and chromatin 3D structure with convolutional neural networks. BMC Genomics. 19(S6). 565–565. 26 indexed citations
16.
Su, Xianbin, Yi Shi, Xin Zou, et al.. (2017). Single-cell RNA-Seq analysis reveals dynamic trajectories during mouse liver development. BMC Genomics. 18(1). 946–946. 54 indexed citations
17.
Sun, Jinghui, Qing Luo, Lingling Liu, & Guanbin Song. (2016). Liver cancer stem cell markers: Progression and therapeutic implications. World Journal of Gastroenterology. 22(13). 3547–3547. 152 indexed citations
18.
Deng, Xiaoyan, et al.. (2014). Effect of Diane-35 on Polycystic Ovarian Syndrome of Different Subtypes. Open Journal of Obstetrics and Gynecology. 4(11). 659–665. 2 indexed citations
19.
Huang, Shujie, et al.. (2014). Correlation between DQB1 genetic polymorphism and genetic susceptibility in patients diagnosed with irritable bowel syndrome with diarrhea. Genetics and Molecular Research. 13(4). 10285–10293. 3 indexed citations
20.
Li, Xiaoming, Qing Luo, & Guanbin Song. (2013). [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].. PubMed. 30(4). 894–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yifeng Zhang Breakdown of academic impact, for papers by Miaomiao Zhang Breakdown of academic impact, for papers by Ning He Breakdown of academic impact, for papers by Lei Yan Breakdown of academic impact, for papers by Lipei Liu Breakdown of academic impact, for papers by Menglin Zhu Breakdown of academic impact, for papers by Yali Cao Breakdown of academic impact, for papers by Luting Zhou
Rankless by CCL
2026